基本資料
種類: ETF
費用比率%: 0.09
資產淨值: 6,452.81
成立日期: 26/01/2004
 
分析
市值分佈:
96.57%
大市值
2.18%
中市值
0.62%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 11/11/2026 04:01) 總持有投資項目: 410  
0%
 
100%
     10大 (51.75%)
代號 名稱 佔比% ▼ 持有日期
TARSTarsus Pharmaceuticals0.0330/09/2026
ACADACADIA Pharmaceuticals0.0330/09/2026
TNGXTango Therapeutics0.0330/09/2026
BKDBrookdale Senior Living0.0330/09/2026
CRVLCorVel Corp0.0330/09/2026
NEONeoGenomics0.0330/09/2026
IMVTImmunovant0.0330/09/2026
SMMTSummit Therapeutics0.0330/09/2026
CLDXCelldex Therapeutics0.0330/09/2026
DYNDyne Therapeutics0.0330/09/2026
ACHCAcadia Healthcare Company0.0330/09/2026
ADMAADMA Biologics0.0330/09/2026
ELVNEnliven Therapeutics0.0330/09/2026
BEAMBeam Therapeutics0.0330/09/2026
UFPTUFP Technologies0.0330/09/2026
PBHPrestige Consumer Healthcare0.0330/09/2026
RLAYRelay Therapeutics0.0330/09/2026
AXGNAxogen0.0330/09/2026
MDPediatrix Medical Group0.0330/09/2026
RCUSArcus Biosciences0.0330/09/2026
  1    2    3    4    5    6    7    8   9    10    11    12    13    14    15    16    17    18    19    20    21  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.